Lv1
50 积分 2024-04-08 加入
Neoadjuvant nivolumab modifies the tumor immune microenvironment in resectable glioblastoma
5个月前
已完结
Discovery and preclinical evaluations of TQB3616, a novel CDK4-biased inhibitor
7个月前
已完结
An open‐label phase II study: The efficiency and safety of anlotinib + eribulin in patients with HER2 ‐negative metastatic breast cancer
9个月前
已完结
Safety and Efficacy of Anlotinib Hydrochloride Plus Temozolomide in Patients with Recurrent Glioblastoma
9个月前
已完结
Nab-paclitaxel weekly versus dose-dense solvent-based paclitaxel followed by dose-dense epirubicin plus cyclophosphamide in high-risk HR+/HER2− early breast cancer: results from the neoadjuvant part of the WSG-ADAPT-HR+/HER2− trial
10个月前
已完结
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
11个月前
已完结
Neoadjuvant chemotherapy plus camrelizumab for locally advanced cervical cancer (NACI study): a multicentre, single-arm, phase 2 trial
1年前
已完结
[Consensus on diagnosis and treatment of Silver-Russell syndrome (2025)]
1年前
已关闭
皖公网安备34019202002308
